FDA Watch: Agency to Allow DTC Marketing of Genetic Tests without Premarket Approval

Email not displaying correctly? View it in your browser.
  Lab and Pathology Insider Logo  
Dec 12, 2017  
placeholder  PRODUCT DEVELOPMENT
FDA Watch: Agency to Allow DTC Marketing of Genetic Tests without Premarket Approval
From - National Intelligence Report
The FDA's longstanding policy of restricting direct-to-consumer (DTC) marketing of products without formal premarket approval is well known. But while it always applied to…
Read More

placeholder  CLFS 2018
Medicare Exclusions: One Week, Two Different Labs Get the Boot
From - G2 Compliance Advisor
The government agency that runs the Medicare program failed to follow a congressional directive to implement a market-based laboratory payment system…
Read More
     


placeholder  FALSE CLAIMS
Labs In Court: A roundup of recent cases and enforcement actions involving the diagnostics industry
From - Laboratory Industry Report
Case: A California cardio clinic and its physician owners will pay $1.2 million to settle charges of falsely billing Medicare and Medicaid for…
Read More

placeholder  REIMBURSEMENT
CMS Final Fee Schedule Will Impact Patient Access to Laboratories: COLA
From - Diagnostic Testing & Emerging Technologies
The CMS Final Fee Schedule will hurt patient access to clinical laboratories, says the lab accreditation bureau COLA…
Read More

 


For questions concerning delivery of this email, please contact customer service at:
(888) 729-2315 | customerservice@plainlanguagemedia.com

Copyright © 2017, All rights reserved.
Plain Language Media LLLP
PO Box 509, New London, CT 06320